Cotransfection of DC with TLR4 and MART-1 RNA induces MART-1-specific responses
- PMID: 15820257
- DOI: 10.1016/j.jss.2004.10.002
Cotransfection of DC with TLR4 and MART-1 RNA induces MART-1-specific responses
Abstract
Background: Cotransfection of dendritic cells (DC) with MART-1 and constitutively active TLR4 (caTLR4) RNA enhances the maturation of DC.
Materials and methods: Immature DC were cotransfected with RNA constructs encoding MART-1 and caTLR4, and CTL responses were analyzed.
Results: Cotransfection of DC with MART-1 + caTLR4 enhanced the expression of CD80 and CD83 surface markers and increased the secretion of cytokines IL-6, IL-12, and TNFalpha. Neither the native nor the A27L-modified MART-1 RNA could induce significant DC maturation or cytokine secretion. More importantly, DC cotransfected with caTLR4 + MART-1 RNA induced MART-1-specific CTL responses of a higher magnitude than DC transfected with either the native or A27L MART-1 RNA. When the MART-1 RNA-transfected DC were treated with DC-maturing cytokines, the induced CTL were less frequent and less lytic than those induced with MART-1 + caTLR4. A 2- to 100-fold increase in MART-1 tetramer+ cells and 2- to 10-fold increases in IFNgamma secretion and cytotoxicity were seen in CTL induced with MART-1 + caTLR4 compared to CTL induced with either MART-1 or A27L RNA. CTL induced with the mixed RNA displayed high percentages of CD8+ cells coexpressing CD45RA, CD56, and 2B4 antigens. Transfection with caTLR4 alone induced DC maturation, but did not induce lytic CTL, suggesting that CTL responses were induced solely by MART-1 epitopes.
Conclusions: caTLR4 increases the CTL-inducing capacity of DC generating a lytic response specific for the accompanying antigen. These results demonstrate the possibility of enhancing the immunogenicity of the native MART-1 and other RNA derived from weakly immunogenic tumors in DC-based immunotherapy.
Similar articles
-
Enhancement of the antigen-specific cytotoxic T lymphocyte-inducing ability in the PMDC11 leukemic plasmacytoid dendritic cell line via lentiviral vector-mediated transduction of the caTLR4 gene.Mol Med Rep. 2015 Aug;12(2):2443-50. doi: 10.3892/mmr.2015.3685. Epub 2015 Apr 24. Mol Med Rep. 2015. PMID: 25936433 Free PMC article.
-
Induction of human dendritic cell maturation using transfection with RNA encoding a dominant positive toll-like receptor 4.J Immunol. 2004 Jun 1;172(11):7162-8. doi: 10.4049/jimmunol.172.11.7162. J Immunol. 2004. PMID: 15153540
-
CD40 ligand is essential for generation of specific cytotoxic T cell responses in RNA-pulsed dendritic cell immunotherapy.Surgery. 2003 Aug;134(2):300-5. doi: 10.1067/msy.2003.240. Surgery. 2003. PMID: 12947333
-
Induction of anti-melanoma CTL response using DC transfected with mutated mRNA encoding full-length Melan-A/MART-1 antigen with an A27L amino acid substitution.Cell Immunol. 2003 Aug;224(2):86-97. doi: 10.1016/j.cellimm.2003.08.005. Cell Immunol. 2003. PMID: 14609574
-
Induction of antigen-specific CD8+ cytotoxic T cells by dendritic cells co-electroporated with a dsRNA analogue and tumor antigen mRNA.Gene Ther. 2006 Jul;13(13):1027-36. doi: 10.1038/sj.gt.3302750. Epub 2006 Mar 2. Gene Ther. 2006. PMID: 16511519
Cited by
-
RNAi-based therapeutics-current status, challenges and prospects.EMBO Mol Med. 2009 Jun;1(3):142-51. doi: 10.1002/emmm.200900023. EMBO Mol Med. 2009. PMID: 20049714 Free PMC article. Review.
-
Introduction of functional chimeric E/L-selectin by RNA electroporation to target dendritic cells from blood to lymph nodes.Cancer Immunol Immunother. 2008 Apr;57(4):467-77. doi: 10.1007/s00262-007-0385-1. Epub 2007 Sep 2. Cancer Immunol Immunother. 2008. PMID: 17768622 Free PMC article.
-
Enhancement of the antigen-specific cytotoxic T lymphocyte-inducing ability in the PMDC11 leukemic plasmacytoid dendritic cell line via lentiviral vector-mediated transduction of the caTLR4 gene.Mol Med Rep. 2015 Aug;12(2):2443-50. doi: 10.3892/mmr.2015.3685. Epub 2015 Apr 24. Mol Med Rep. 2015. PMID: 25936433 Free PMC article.
-
Current progress of siRNA/shRNA therapeutics in clinical trials.Biotechnol J. 2011 Sep;6(9):1130-46. doi: 10.1002/biot.201100054. Epub 2011 Jul 11. Biotechnol J. 2011. PMID: 21744502 Free PMC article. Review.
-
Type 2 Bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cells.Cancer Res. 2008 Nov 15;68(22):9441-50. doi: 10.1158/0008-5472.CAN-08-0900. Cancer Res. 2008. PMID: 19010919 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials